VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2019 | Challenges in the treatment of CMV

Hermann Einsele
EBMT 2019
General

Here, Hermann Einsele, MD, FRCP, of University Hospital Würzburg, Würzburg, Germany, talks about the challenges in treating cytomegalovirus (CMV), at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Hermann Einsele

19:05
Immunotherapy for myeloma: past, present, future
Hermann Einsele • 22 May 2020
4:42
CAR-T for myeloma: ongoing trials
Hermann Einsele • 22 May 2020
1:52
Improving the outcomes of transplantation with bispecific antibodies
Hermann Einsele • 28 Mar 2017
1:14
The CAR T-cell strategy vs bispecific antibodies
Hermann Einsele

Related Videos

2:42
Current CAR-T clinical trials in China
Peihua Lu • 14 Dec 2020
5:56
Features of COVID-19 infection in hematology patients
William Wood • 14 Dec 2020
6:36
Highlights from ASH 2020: BiTEs in myeloma
Mohamad Mohty • 7 Dec 2020
3:08
Defibrotide treatment in VOD/SOS patients
Mohamad Mohty • 7 Dec 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals